Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE American:NBY)

4.45
Delayed Data
As of 3:58pm ET
 +0.10 / +2.30%
Today’s Change
2.25
Today|||52-Week Range
5.09
+34.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues3.4M4.1M3.7M4.1M
 
 
 
 
 
Cost of Goods Sold535.0K792.0K570.0K680.0K
 
 
 
 
 
Depreciation And Amortization31.0K16.0K18.0K18.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.9M3.3M3.1M3.4M
 
 
 
 
 
General Expenses5.1M5.3M6.9M5.2M
 
 
 
 
 
Research And Development236.0K156.0K62.0K70.0K
 
 
 
 
 
Total Operating Expenses5.6M6.1M7.5M5.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.2M-2.0M-3.8M-1.8M
 
 
 
 
 
Extraordinary Credit0.00381.0K--15.0K
 
 
 
Extraordinary Charge-1.7M---235.0K--
 
 
 
Other Expenses180.0K1.0K2.0K4.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.7M-1.6M-4.0M-1.7M
 
 
 
 
 
Income Taxes0.000.00-1.0K0.00
 
 
Net Income-3.7M-1.6M-4.0M-1.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.9M15.1M15.3M15.3M
 
 
 
 
 
Shares To Calculate EPS Diluted10.9M15.5M15.3M15.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.13-$0.26-$0.11
 
 
 
 
 
EPS Diluted-$0.34-$0.11-$0.26-$0.11